Publications
Selected Publications
Poggi G*, Queisser D*, Senn A*, Kúkeľová D, Madur L, Cuomo-Haymour N, Robert M, Schmid S, Simard S, Mechawar N, Hengerer B, Just S, Pryce CR. (2025). TRP canonical 4 and/or 5 channel inhibiton reduces aversion- and increases reward-responding in chronically stressed mice. British Journal of Pharmacology, 2025; 1-27. doi.org/10.1111/bph.70305.
Poggi G*, Portales A*, Robert M*, Hofer C, Schmid S, Kúkeľová D, Sigrist H, Just S, Hengerer B, Pryce CR. (2025). Chronic social stress induces generalized hyper-sensitivity to aversion: a mouse model with translational predictive validity for novel treatments in negative valence disorders. Neuropharmacology, 273: 110430. doi: 10.1016/j.neuropharm.2025.110430.
Zhang C, Kukelova D, Sigrist H, Hengerer B, Kratzer RF, Mracek P, Omrani A, von Heimendahl M, Pryce CR. (2024). Efficacy of orphan receptor GPR52 inverse agonism in ameliorating chronic stress-related deficits in reward motivation and phasic accumbal dopamine activity in mice. Translational Psychiatry, 14:363. doi.org: /10.1038/s41398-024-03081-w.
Zhang C*, Dulinskas R*, Ineichen C, Greter A, Sigrist H, Li Y, Alanis-Lobato G, Hengerer B, Pryce CR. (2024). Chronic stress deficits in reward behaviour are underlain by low nucleus accumbens dopamine activity during reward anticipation specifically. Communications Biology, 7:966. doi: 10.1038/s42003-024-06658-9.
Sigrist H, Senn A, Hogg DE, Pryce CR. (2024). Mouse model of chronic social stress-induced excessive Pavlovian aversion learning-memory. Current Protocols, e1008, vol. 4. doi: 10.1002/cpz1.1008.
Poggi G, Bergamini G, Dulinskas R, Madur L, Greter A, Ineichen C, Dagostino A, Kúkeľová D, Sigrist H, Bornemann KD, Hengerer B, Pryce CR. (2024). Engagement of basal amygdala-nucleus accumbens glutamate neurons in the processing of rewarding or aversive social stimuli. European Journal of Neuroscience, 59: 996-1015. doi: 10.1111/ejn.16272.
Madur L*, Ineichen C*, Bergamini G, Greter A, Poggi G, Sigrist H, Sych Y, Paterna J-C, Bornemann KD, Viollet C, Fernandez-Albert F, Alanis-Lobato G, Hengerer B, Pryce CR. (2023). Stress deficits in reward behaviour are associated with and replicated by dysregulated amygdala-nucleus accumbens pathway function in mice. Communications Biology, 6:422. doi: 10.1038/s42003-023-04811-4
Adamcyzk I, Kúkeľová D, Just S, Giovannini R, Sigrist H, Amport R, Cuomo-Haymour N, Poggi G, Pryce CR. (2021). Somatostatin receptor 4 agonism normalizes stress-related excessive amygdala glutamate release and Pavlovian aversion learning and memory in rodents. Biological Psychiatry: Global Open Science, in press.2:470-479. doi: 10.1016/j.bpsgos.2021.11.006.
Bergamini G, Mechtersheimer J, Azzinnari D, Sigrist H, Buerge M, Dallmann R, Freije R, Seifritz E, Ferger B, Suter T, Pryce CR. (2018). Mouse chronic social stress induces peripheral and brain immune activation, blunted mesolimbic dopamine function, and reduced interest in reward. Neurobiology of Stress, 8: 42-56. DOI: 10.1016/j.ynstr.2018.01.004
Just S, Chenard BL, Ceci A, Strassmaier T, Chong JA, Blair NT, Gallaschun RJ, del Camino D, Cantin S, D’Amours M, Eickmeier C, Fanger CM, Hecker C, Hessler DP, Hengerer B, Kroker KS, Malekiani S, Mihalek R, McLaughlin J, Rast G, Witek J, Sauer A, Pryce CR, Moran MM. (2018). Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice. PLOS ONE, 13(1): e0191225. DOI: 10.1371/journal.pone.0191225
Grandjean J, Azzinnari D, Seuwen A, Sigrist H, Seifritz E, Pryce CR.*, Rudin M* (2016). Chronic psychosocial stress in mice leads to changes in brain functional connectivity and metabolite levels comparable to human depression. NeuroImage, 142: 544-552. DOI: 10.1016/j.neuroimage.2016.08.013
Azzinnari D, Sigrist H, Staehli S, Palme R, Hildebrandt T, Leparc G, Hengerer B, Seifritz E, Pryce CR. (2014). Mouse social stress induces increased fear conditioning, helplessness and fatigue to physical challenge together with markers of altered immune and dopamine function. Neuropharmacology, 85: 328-341. DOI: 10.1016/j.neuropharm.2014.05.039
https://www.webofscience.com/wos/alldb/basic-search
Author Identifier: ABF-9328-2022